Petri Reponen
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Pollution top 10%
- Pesticide and Herbicide Environmental Studies
Papers in
- Pharmacology 13
- Pharmacogenetics and Drug Metabolism 12
- Drug-Induced Hepatotoxicity and Protection 4
- Oncology 8
- Drug Transport and Resistance Mechanisms 8
- Co-authors
- Olavi Pelkonen (14 shared papers)Khaled Abass (13 shared papers)Sampo Mattila (7 shared papers)Jorma Jalonen (3 shared papers)Miia Turpeinen (3 shared papers)Jenni Küblbeck (2 shared papers)Paavo Honkakoski (2 shared papers)Jukka Hakkola (1 shared paper)
- Journals
- Chemico-Biological Interactions (2 papers)Toxicology Reports (2 papers)Environmental Toxicology and Pharmacology (2 papers)Toxicology Letters (2 papers)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- FinlandEgyptSaudi Arabia
In The Last Decade
Petri Reponen
17 papers receiving 509 citations
Peers
Comparison fields: 5 of 86
- Pharmacology 163
- Pollution 108
- Health, Toxicology and Mutagenesis 82
- Anesthesiology and Pain Medicine 25
- Pharmacology 62
Countries citing papers authored by Petri Reponen
This map shows the geographic impact of Petri Reponen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petri Reponen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petri Reponen more than expected).
Fields of papers citing papers by Petri Reponen
This network shows the impact of papers produced by Petri Reponen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petri Reponen. The network helps show where Petri Reponen may publish in the future.
Co-authors
The 25 scholars most cited alongside Petri Reponen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 88 | |
| 2 | 2006 | 56 | |
| 3 | 2007 | 56 | |
| 4 | 2006 | 47 | |
| 5 | 2007 | 40 | |
| 6 | 2011 | 40 | |
| 7 | 2006 | 37 | |
| 8 | 2010 | 31 | |
| 9 | 2016 | 28 | |
| 10 | 2009 | 27 | |
| 11 | 2010 | 24 | |
| 12 | 2013 | 22 | |
| 13 | 2013 | 19 | |
| 14 | 2023 | 10 | |
| 15 | 2010 | 6 | |
| 16 | 2022 | 4 | |
| 17 | 2022 | 1 |
About Petri Reponen
Petri Reponen is a scholar working on Pharmacology, Oncology, Plant Science, Molecular Biology and Pharmacology, having authored 17 papers that have together received 536 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (8 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Pesticide Exposure and Toxicity (3 papers), Pesticide and Herbicide Environmental Studies (2 papers), Eicosanoids and Hypertension Pharmacology (1 paper), Plant biochemistry and biosynthesis (1 paper) and Schizophrenia research and treatment (1 paper). The work is most often cited by research in Pharmacology (163 citations), Pollution (108 citations), Health, Toxicology and Mutagenesis (82 citations), Anesthesiology and Pain Medicine (25 citations) and Pharmacology (62 citations). Petri Reponen has collaborated with scholars based in Finland, Egypt and Saudi Arabia. Frequent co-authors include Olavi Pelkonen, Khaled Abass, Sampo Mattila, Jorma Jalonen, Miia Turpeinen, Jenni Küblbeck, Paavo Honkakoski, Jukka Hakkola, Arja Rautio and Tero Ala‐Kokko. Their work appears in journals such as Chemico-Biological Interactions, Toxicology Reports, Environmental Toxicology and Pharmacology, Toxicology Letters and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.